脉络丛形态改变与阿尔茨海默病病理及认知障碍的纵向关联
本研究基于阿尔茨海默病神经影像学倡议(ADNI)中564例无痴呆参与者的回顾性数据,利用深度学习分割脉络丛并分析其高阶形态特征。结果显示AD病理与脉络丛肥大、形状不规则及信号不均匀相关,这些特征可介导AD病理与认知评分的关系,并在Aβ阳性参与者中预测纵向认知下降。
要点
- AD病理与脉络丛肥大、形状不规则及信号不均匀相关。
- 脉络丛形态特征可介导AD病理与MoCA评分的关系。
- 脉络丛特征可预测Aβ阳性者纵向认知下降。
核心结论
- AD病理可能破坏脉络丛结构,进而促进临床进展。
研究设计与样本
- 回顾性研究,纳入ADNI中564例无痴呆参与者,平均年龄72.4±7.7岁,女性占54.1%。
主要发现
- AD病理与脉络丛肥大、形状不规则及信号不均匀相关(所有p<0.05,FDR校正)。
- 脉络丛特征介导AD病理与MoCA评分关联(标准化β=-0.023,95%CI -0.048至-0.001,p=0.048)。
- 在Aβ+参与者中,脉络丛特征预测纵向MMSE下降(β=-0.148,95%CI -0.287至-0.009,p=0.038)。
- 在Aβ+参与者中,脉络丛特征预测纵向ADAS-Cog升高(β=0.467,95%CI 0.110至0.824,p=0.011)。
- 在Aβ+参与者中,脉络丛特征预测纵向CDR-SB升高(β=0.098,95%CI 0.016至0.180,p=0.022)。
临床怎么用
- 脉络丛形态特征或可作为AD病理影响认知的影像学中介标志物。
- 对Aβ阳性个体,脉络丛形态特征有助于预测认知下降轨迹。
局限性
- 脉络丛形态特征的病理学基础尚未明确,需影像-组织病理对照研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The choroid plexus (ChP) plays a crucial role in maintaining brain health. Alzheimer disease (AD) pathologies may damage the ChP and accelerate neurodegeneration. Previous imaging studies have found overall increased ChP volume in patients with AD. In this study, we aim to investigate AD-related ChP morphological features and their associations with cognitive decline. METHODS: This retrospective study used data from participants without dementia enrolled in the Alzheimer's Disease Neuroimaging Initiative, a large multicenter project. We included participants with complete 3D T1 and 3D fluid-attenuated inversion recovery MRI, β-amyloid (Aβ) and tau PET, and cognitive assessments. Follow-up cognitive data were collected when available. We developed a deep learning-based segmentation method for accurate ChP segmentation and analyzed the high-order morphological features of the ChP. First, we selected AD-related ChP features using partial correlation analyses. Then, partial correlation analyses and chain mediation analyses were performed to investigate the associations between the ChP features and cognitive scores. Finally, linear mixed models were used to investigate whether the ChP features could predict cognitive decline over time. RESULTS: A total of 564 participants without dementia (mean age 72.4 ± 7.7 years; 54.1% female) were included: 339 with Aβ- and 225 with Aβ+. AD pathologies were associated with hypertrophy, irregular shapes, and nonuniform signals of the ChP (all p < 0.05, false discovery rate corrected). The ChP features could act as mediators between AD pathologies and Montreal Cognitive Assessment (standardized β = -0.023, 95% CI -0.048 to -0.001, p = 0.048) and predict longitudinal cognitive decline in Aβ+ participants over time (Mini-Mental State Examination: β = -0.148, 95% CI -0.287 to -0.009, p = 0.038; Alzheimer's Disease Assessment Scale-Cognitive: β = 0.467, 95% CI 0.110-0.824, p = 0.011; Clinical Dementia Rating-Sum of Boxes: β = 0.098, 95% CI 0.016-0.180, p = 0.022). DISCUSSION: Our approach captured the complex morphological alterations of the ChP in AD. These findings provide valuable knowledge that AD pathologies may disrupt ChP structure, contributing to clinical progression. The pathologic substrates underlying these ChP morphological features remain to be elucidated, necessitating further investigation through imaging-histopathological comparison studies.
引用
- Lin M, Zeng Q, Zhong S, et al. Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study. Neurology. 2025. PMID: 41284956. doi:10.1212/WNL.0000000000213953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。